MedPath

GlaxoSmithKline

GlaxoSmithKline logo
🇬🇧United Kingdom
Ownership
Public
Established
1929-01-01
Employees
70.2K
Market Cap
$90B
Website
http://www.gsk.com
Introduction

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

GSK2983559 First Time in Human Study

Phase 1
Terminated
Conditions
Inflammatory Bowel Diseases
Interventions
Drug: GSK2983559
Drug: Placebo
First Posted Date
2017-11-30
Last Posted Date
2020-11-27
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
31
Registration Number
NCT03358407
Locations
🇬🇧

GSK Investigational Site, Cambridge, Cambridgeshire, United Kingdom

Sensor and Electronic Health Records (EHR) Integration Pilot Study

Completed
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
Device: Mobile spirometer
Device: Device sensor
Drug: Salbutamol
Device: Activity monitor
Other: ACT
Other: electronic diary card
Other: CAT
First Posted Date
2017-11-29
Last Posted Date
2020-11-24
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
194
Registration Number
NCT03357341
Locations
🇺🇸

GSK Investigational Site, Danville, Pennsylvania, United States

A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study

Phase 3
Completed
Conditions
Cervical Intraepithelial Neoplasia
Interventions
Procedure: Blood sampling for antibody determination
First Posted Date
2017-11-28
Last Posted Date
2020-11-19
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
228
Registration Number
NCT03355820
Locations
🇨🇳

GSK Investigational Site, Taizhou, Jiangsu, China

Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function

Completed
Conditions
Neoplasms
Interventions
Other: Qualitative Interviews
Other: PROMIS Physical Function Items
First Posted Date
2017-11-22
Last Posted Date
2021-07-14
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
1
Registration Number
NCT03351140
Locations
🇺🇸

GSK Investigational Site, Mountlake Terrace, Washington, United States

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

First Posted Date
2017-11-17
Last Posted Date
2021-07-14
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
943
Registration Number
NCT03345407
Locations
🇬🇧

GSK Investigational Site, Stockton-on-Tees, United Kingdom

A Study to Evaluate Conceptual Saturation of Evaluating Respiratory Symptoms (E-RS) in Subjects With Asthma

Completed
Conditions
Asthma
Interventions
Other: Telephonic interviews
Other: Supplemental asthma items
Other: Daily diary
Other: Sociodemographic questionnaire
Other: Clinical questionnaire
First Posted Date
2017-11-17
Last Posted Date
2019-04-16
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
25
Registration Number
NCT03344406
Locations
🇺🇸

GSK Investigational Site, Pittsburgh, Pennsylvania, United States

A Study to Investigate a Method to Measure Food Occlusion by Denture Adhesives in Denture Wearers

Not Applicable
Completed
Conditions
Denture Retention
Interventions
Device: Denture Adhesive Cream (Conventional Application)
Device: Denture Adhesive (Continuous Strip Application)
Other: No Adhesive
First Posted Date
2017-11-17
Last Posted Date
2019-03-29
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
48
Registration Number
NCT03345108
Locations
🇺🇸

GSK Investigational Site, Fort Wayne, Indiana, United States

Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer

Completed
Conditions
Neoplasms
Interventions
Other: Telephonic interview
First Posted Date
2017-11-08
Last Posted Date
2019-02-05
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
40
Registration Number
NCT03336567
Locations
🇺🇸

GSK Investigational Site, Collegeville, Pennsylvania, United States

A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions

Phase 1
Withdrawn
Conditions
Infections, Bacterial
Interventions
First Posted Date
2017-11-06
Last Posted Date
2018-03-07
Lead Sponsor
GlaxoSmithKline
Registration Number
NCT03329547

Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects

Phase 1
Completed
Conditions
Anxiety Disorders
Interventions
First Posted Date
2017-11-06
Last Posted Date
2020-03-27
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
85
Registration Number
NCT03329573
Locations
🇨🇳

GSK Investigational Site, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath